Catalio Capital

United States
Firm Location:United States • Massachusetts • New York, New York • Los Angeles, California • Houston, Texas • San Diego, California • San Francisco, California • Boston, Massachusetts • Baltimore, Maryland • Sacramento, California • Fairfield, California • Cambridge, Massachusetts • Boulder, Colorado • Weston, Florida • Bethesda • Stanford, California • New York City • United Kingdom
Catalio Capital Team
Photo of Leslie A. Leinwand, Venture Partner at Catalio Capital
Leslie A. Leinwand
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Denver (CO), Investors in Boulder (CO)
Photo of João Amorim, Analyst at Catalio Capital
João Amorim
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Pharmaceuticals (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Boston / New England (Other Lists)
Photo of Michael A. Rogawski, Venture Partner at Catalio Capital
Michael A. Rogawski
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Sacramento (CA)
Photo of Alan Ashworth, Venture Partner at Catalio Capital
Alan Ashworth
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in San Francisco (CA)
Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in San Francisco Bay Area (Other Lists)
Photo of Holly Barra, Analyst at Catalio Capital
Holly Barra
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Baltimore (MD), Investors in Rockville (MD), Investors in Washington (D.C.), Investors in New York (NY)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Washington, D.C. (Other Lists), Investors in New York City (Other Lists)
Photo of Regina Barzilay, Venture Partner at Catalio Capital
Regina Barzilay
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA), Investors in Cambridge (MA)
Investors in Data Services (Seed), Investors in AI (Seed), Investors in Data Services (Seed), Investors in AI (Seed), Investors in Data Services (Series A), Investors in AI (Series A), Investors in Data Services (Series A), Investors in AI (Series A), Investors in Boston / New England (Other Lists)
Photo of Benjamin Bell, Analyst at Catalio Capital
Benjamin Bell
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA), Investors in Baltimore (MD)
Investors in Pharmaceuticals (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Washington, D.C. (Other Lists), Investors in Boston / New England (Other Lists)
Photo of Henry Brem, Venture Partner at Catalio Capital
Henry Brem
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA), Investors in Baltimore (MD)
Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in BioTech (Seed), Investors in Drug Delivery (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series A), Investors in BioTech (Series A), Investors in Drug Delivery (Series A), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Washington, D.C. (Other Lists), Investors in Boston / New England (Other Lists)
Photo of George C. Petrocheilos, Managing Partner at Catalio Capital
George C. Petrocheilos
Catalio Capital·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Baltimore (MD), Investors in Athens (Greece), Investors in New York (NY)
Investors in Diagnostics (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Cybersecurity (Seed), Investors in Medical Devices (Seed), Investors in Diagnostics (Seed), Investors in Drug Delivery (Seed), Investors in Robotics (Seed), Investors in BioTech (Seed), Investors in Cybersecurity (Seed), Investors in Diagnostics (Seed), Investors in Medical Devices (Seed), Investors in Robotics (Seed), Investors in BioTech (Seed), Investors in Medical Devices (Seed), Investors in Cybersecurity (Seed), Investors in Robotics (Seed), Investors in BioTech (Seed), Investors in Diagnostics (Series A), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series A), Investors in Cybersecurity (Series A), Investors in Medical Devices (Series A), Investors in Drug Delivery (Series A), Investors in Diagnostics (Series A), Investors in Robotics (Series A), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in Diagnostics (Series A), Investors in Cybersecurity (Series A), Investors in Robotics (Series A), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in Cybersecurity (Series A), Investors in Robotics (Series A), Investors in BioTech (Series A), Investors in Robotics (Series B), Investors in Diagnostics (Series B), Investors in Drug Delivery (Series B), Investors in Cybersecurity (Series B), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B), Investors in Diagnostics (Series B), Investors in Medical Devices (Series B), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Diagnostics (Series B), Investors in Cybersecurity (Series B), Investors in Robotics (Series B), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Robotics (Series B), Investors in Cybersecurity (Series B), Investors in BioTech (Series B), Investors in Washington, D.C. (Other Lists), Investors in New York City (Other Lists)
Photo of Thomas C. Südhof, Venture Partner at Catalio Capital
Thomas C. Südhof
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Stanford (CA)
Investors in Pharmaceuticals (Seed), Investors in Digital Health (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in San Francisco Bay Area (Other Lists)
Photo of Eugene de Juan Jr, Venture Partner at Catalio Capital
Eugene de Juan Jr
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in SF Bay Area (CA), Investors in San Francisco (CA)
Photo of Titia de Lange, Venture Partner at Catalio Capital
Titia de Lange
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in San Francisco (CA)
Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in San Francisco Bay Area (Other Lists)
Photo of Philip D. Greenberg, Venture Partner at Catalio Capital
Philip D. Greenberg
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY), Investors in United States
Investors in Pharmaceuticals (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in New York City (Other Lists)
Photo of Christine E. 'Kricket'  Seidman, Venture Partner at Catalio Capital
Christine E. 'Kricket' Seidman
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in SF Bay Area (CA), Investors in San Francisco (CA)
Investors in Pharmaceuticals (Seed), Investors in Digital Health (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in San Francisco Bay Area (Other Lists)
Photo of Napoleone Ferrara, Venture Partner at Catalio Capital
Napoleone Ferrara
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in San Diego (CA)
Photo of Jenna Glatzer, Analyst at Catalio Capital
Jenna Glatzer
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Rochester (NY), Investors in Baltimore (MD)
Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Washington, D.C. (Other Lists), Investors in New York City (Other Lists)
Photo of Nicholas von Guionneau, Analyst at Catalio Capital
Nicholas von Guionneau
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in United Kingdom
Photo of Justin Hanes, Venture Partner at Catalio Capital
Justin Hanes
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA), Investors in Waltham (MA), Investors in Baltimore (MD)
Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Pharmaceuticals (Seed), Investors in Drug Delivery (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Washington, D.C. (Other Lists), Investors in Boston / New England (Other Lists)
Photo of Frances H. Arnold, Venture Partner at Catalio Capital
Frances H. Arnold
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in San Diego (CA), Investors in Santa Monica (CA), Investors in Los Angeles (CA)
Investors in Chemicals (Seed), Investors in Pharmaceuticals (Seed), Investors in Chemicals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Chemicals (Series A), Investors in Pharmaceuticals (Series A), Investors in Chemicals (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Los Angeles / Southern California (Other Lists)
Photo of Matthew Hobson, Analyst at Catalio Capital
Matthew Hobson
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Baltimore (MD)
Investors in Pharmaceuticals (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Washington, D.C. (Other Lists)
Photo of Solomon H. Snyder, Venture Partner at Catalio Capital
Solomon H. Snyder
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Baltimore (MD)
Photo of Jim J. Collins, Venture Partner at Catalio Capital
Jim J. Collins
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY)
Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in BioTech (Series B), Investors in New York City (Other Lists)
Photo of Jeffrey Karp, Venture Partner at Catalio Capital
Jeffrey Karp
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Photo of Raju Kucherlapati, Venture Partner at Catalio Capital
Raju Kucherlapati
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA), Investors in Weston (FL)
Photo of Freda Lewis-Hall, Venture Partner at Catalio Capital
Freda Lewis-Hall
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY)
Photo of Dan Littman, Venture Partner at Catalio Capital
Dan Littman
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY)
Investors in BioTech (Series B), Investors in BioTech (Series B), Investors in New York City (Other Lists)
Photo of Nathan Livingston, Analyst at Catalio Capital
Nathan Livingston
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Baltimore (MD)
Photo of Gregg L. Semenza, Venture Partner at Catalio Capital
Gregg L. Semenza
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Baltimore (MD)
Investors in Pharmaceuticals (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Washington, D.C. (Other Lists)
Photo of Lauren Maslin, Analyst at Catalio Capital
Lauren Maslin
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York City, Investors in Baltimore (MD)
Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Washington, D.C. (Other Lists), Investors in New York City (Other Lists)
Photo of George M. Church, Venture Partner at Catalio Capital
George M. Church
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in SF Bay Area (CA), Investors in Cambridge (MA), Investors in Boston (MA)
Investors in BioTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in BioTech (Series B), Investors in BioTech (Series B), Investors in Boston / New England (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Jeffrey M. Friedman, Venture Partner at Catalio Capital
Jeffrey M. Friedman
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York City
Investors in Pharmaceuticals (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in New York City (Other Lists)
Photo of Samir Mitragotri, Venture Partner at Catalio Capital
Samir Mitragotri
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Santa Barbara (CA), Investors in Boston (MA), Investors in Cambridge (MA)
Photo of Drew M. Pardoll, Venture Partner at Catalio Capital
Drew M. Pardoll
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Baltimore (MD)
Investors in Pharmaceuticals (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Washington, D.C. (Other Lists)
Photo of Sangeeta N. Bhatia, Venture Partner at Catalio Capital
Sangeeta N. Bhatia
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Massachusetts, Investors in San Diego (CA), Investors in Cambridge (MA)
Investors in Drug Delivery (Seed), Investors in Diagnostics (Seed), Investors in Drug Delivery (Seed), Investors in Diagnostics (Seed), Investors in Drug Delivery (Seed), Investors in BioTech (Seed), Investors in Diagnostics (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Drug Delivery (Series A), Investors in Diagnostics (Series A), Investors in Drug Delivery (Series A), Investors in Diagnostics (Series A), Investors in Drug Delivery (Series A), Investors in BioTech (Series A), Investors in Diagnostics (Series A), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Los Angeles / Southern California (Other Lists), Investors in Boston / New England (Other Lists)
Photo of William R. Brody, Venture Partner at Catalio Capital
William R. Brody
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Philadelphia (PA), Investors in San Francisco (CA)
Investors in Medical Devices (Seed), Investors in Medical Devices (Seed), Investors in BioTech (Seed), Investors in Medical Devices (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Medical Devices (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in New York City (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Adam Riess, Venture Partner at Catalio Capital
Adam Riess
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY)
Investors in Space (Seed), Investors in Data Services (Seed), Investors in AI (Seed), Investors in Space (Seed), Investors in Data Services (Seed), Investors in AI (Seed), Investors in Space (Series A), Investors in Data Services (Series A), Investors in Space (Series A), Investors in AI (Series A), Investors in Data Services (Series A), Investors in AI (Series A), Investors in New York City (Other Lists)
Photo of Josh Samuelson, Advisor at Catalio Capital
Josh Samuelson
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Fairfield (CA)
Investors in Pharmaceuticals (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in San Francisco Bay Area (Other Lists)
Photo of Joan S. Brugge, Venture Partner at Catalio Capital
Joan S. Brugge
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series B), Investors in BioTech (Series B), Investors in Boston / New England (Other Lists)
Photo of Padmanee 'Pam' Sharma, Venture Partner at Catalio Capital
Padmanee 'Pam' Sharma
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Houston (TX)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Pharmaceuticals (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Austin (Other Lists)
Photo of David Sinclair, Venture Partner at Catalio Capital
David Sinclair
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Cambridge (MA), Investors in Sydney (Australia), Investors in SF Bay Area (CA), Investors in Boston (MA)
Investors in Consumer Health (Seed), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in BioTech (Seed), Investors in Consumer Health (Series A), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Series A), Investors in Boston / New England (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Maria Sirenko, Analyst at Catalio Capital
Maria Sirenko
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York City
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in New York City (Other Lists)
Photo of Barbara Slusher, Venture Partner at Catalio Capital
Barbara Slusher
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Baltimore (MD)
Photo of Paula T. Hammond, Venture Partner at Catalio Capital
Paula T. Hammond
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Cambridge (MA), Investors in Massachusetts
Photo of C. Giovanni Traverso, Venture Partner at Catalio Capital
C. Giovanni Traverso
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA), Investors in Cambridge (MA)
Photo of Tom V. Brooks, General Partner at Catalio Capital
Tom V. Brooks
Catalio Capital·General Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Denver (CO), Investors in Baltimore (MD)
Investors in Pharmaceuticals (Seed), Investors in Digital Health (Seed), Investors in EnergyTech (Seed), Investors in EnergyTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in EnergyTech (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in EnergyTech (Series A), Investors in EnergyTech (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in EnergyTech (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Colorado / Utah (Other Lists), Investors in Washington, D.C. (Other Lists)
Photo of R. Jacob Vogelstein, Managing Partner at Catalio Capital
R. Jacob Vogelstein
Catalio Capital·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Washington (D.C.), Investors in Baltimore (MD), Investors in Bethesda
Investors in Drug Delivery (Series A), Investors in Diagnostics (Series A), Investors in Medical Devices (Series A), Investors in Drug Delivery (Series A), Investors in AI (Series A), Investors in BioTech (Series A), Investors in Diagnostics (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in Drug Delivery (Series B), Investors in Diagnostics (Series B), Investors in Drug Delivery (Series B), Investors in Medical Devices (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Diagnostics (Series B), Investors in Medical Devices (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Washington, D.C. (Other Lists)
Photo of Bert Vogelstein, Venture Partner at Catalio Capital
Bert Vogelstein
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Cambridge (MA), Investors in Boston (MA), Investors in Baltimore (MD)
Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in BioTech (Seed), Investors in Diagnostics (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in BioTech (Series A), Investors in Diagnostics (Series A), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Washington, D.C. (Other Lists), Investors in Boston / New England (Other Lists)
Photo of Gordana Vunjak-Novakovic, Venture Partner at Catalio Capital
Gordana Vunjak-Novakovic
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY)
Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in New York City (Other Lists)
Photo of Diamantis Xylas, Analyst at Catalio Capital
Diamantis Xylas
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in London, Investors in Baltimore (MD), Investors in New York (NY)
Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Washington, D.C. (Other Lists), Investors in London (Other Lists), Investors in New York City (Other Lists)
Photo of Elias Zerhouni, Venture Partner at Catalio Capital
Elias Zerhouni
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Baltimore (MD)